237,612 research outputs found
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
No full textOral capecitabine (Xeloda<sup>®</sup>) is an effective drug with favourable safety in adjuvant and metastatic colorectal cancer. Oxaliplatin-based therapy is becoming standard for Dukes' C colon cancer in patients suitable for combination therapy, but is not yet approved by the UK National Institute for Health and Clinical Excellence (NICE) in the adjuvant setting. Adjuvant capecitabine is at least as effective as 5-fluorouracil/leucovorin (5-FU/LV), with significant superiority in relapse-free survival and a trend towards improved disease-free and overall survival. We assessed the cost-effectiveness of adjuvant capecitabine from payer (UK National Health Service (NHS)) and societal perspectives. We used clinical trial data and published sources to estimate incremental direct and societal costs and gains in quality-adjusted life months (QALMs). Acquisition costs were higher for capecitabine than 5-FU/LV, but higher 5-FU/LV administration costs resulted in 57% lower chemotherapy costs for capecitabine. Capecitabine vs 5-FU/LV-associated adverse events required fewer medications and hospitalisations (cost savings £3653). Societal costs, including patient travel/time costs, were reduced by >75% with capecitabine vs 5-FU/LV (cost savings £1318), with lifetime gain in QALMs of 9 months. Medical resource utilisation is significantly decreased with capecitabine vs 5-FU/LV, with cost savings to the NHS and society. Capecitabine is also projected to increase life expectancy vs 5-FU/LV. Cost savings and better outcomes make capecitabine a preferred adjuvant therapy for Dukes' C colon cancer. This pharmacoeconomic analysis strongly supports replacing 5-FU/LV with capecitabine in the adjuvant treatment of colon cancer in the UK
O kung Fu e o desenvolvimento infantil : desenvolvimento motor
No full textEste trabalho busca elementos para verificar a ligação do Kung Fu, uma arte
marcial chinesa, com o desenvolvimento motor infantil, baseando-se no conceito do
desenvolvimento motor de GALLAHUE, D. L.; OZMUN, J. C e MEINEL, K., e assim poder
associar estes conceitos a pratica desta, que atualmente é uma das artes marciais mais praticadas
no mundo. Mas antes de apresentar o desenvolvimento motor, passa-se por uma revisão da
história do Kung Fu, e uma revisão sobre o desenvolvimento, para que se possa desenvolver
com clareza a idéia da ligação das duas coisas. Durante a pesquisa foi realizado como forma de
busca de dados, um sistema de diário de observação de alunos praticantes de Kung Fu em
diversos níveis de aprendizagem e treinamento, respeitando a faixa etária proposta pelo trabalho,
para poder apresentar conclusões consistentes. Sem aprofundar-se no tipo de treinamento
realizado e nos estilos existentes da modalidade esportiva, mas se atentando exclusivamente as
crianças no treinamento, com os dados coletados, foi possível observar uma grande relação entre
o Kung Fu e a melhora do desenvolvimento de capacidades como coordenação motora geral,
equilíbrio, lateralidade, noção de direita e esquerda, posição e sentido.This paper searches for elements to verify the connection of Kung Fu, a
Chinese martial art, with the motor development of children, based on the concept of motor
development of GALLAHUE, D. L.; OZMUN, J. C e MEINEL, K., and this way be able to
associate these concepts to it, which is currently one of the most practiced martial arts in the
world. But before presenting the motor development, it will go through a review of the history
of Kung Fu, and a review about the development, so that it can develop a clear idea of the
connection of both things. During the research it was conducted as a way of data searching, a
system of observation journal of students practicing Kung Fu at different levels of learning and
training, respecting the age proposed for the work, to present consistent conclusions. Without
going too deep into the kind of training conducted and in the different existing styles of the
sport, but exclusively paying attention to the children in training, with the collected data, it was
possible to observe a strong relation between Kung Fu and the improvement of capacities as
general motor coordination, balance, laterality, sense of right and left, position and direction
Mutation frequencies following the 5-FU-, 4NQO-, and CPT-treatment.
No full textA), C), and E) The frequencies of overall Lys+ mutations following treatments with 5-FU (10 μM), CPT (100 μM), or 4NQO (0.2 μg/mL), respectively, for 24 hrs. B), D), and F) The frequencies of the uracil-dependent A>C and T>G mutations following treatments with 5-FU, CPT and 4NQO, respectively. Error bars indicate 95% confidence intervals. The number of cultures used to determine the frequencies of mutations and the numerical values of the median mutation frequencies and the confidence intervals represented as graphs in this figure are listed in S4 Table.</p
Dr. Frank Fu, c. 1979
No full textA portrait photograph of Dr. Frank H. Fu (Fu Haojian). The photograph was used in news stories on Dr. Fu for his work and his appointment as Director of Springfield College's International Center.An author of 17 textbooks and more than 100 journal articles, Frank H. Fu, G’73, DPE’75, has worked across the world in China, Canada, and the United States. Throughout his career, he has received many distinguished honors, including the Medal of Honor in 2009 by the SAR Government of Hong Kong.
Fu has held positions at institutions such as the Chinese University of Hong Kong and Springfield College, where he served as director of the International Center starting in 1978. Five years later, Fu returned to Hong Kong, but has since remained actively involved with Springfield College, participating in talks on the campus and even hosting a gathering of nearly 60 alumni in Hong Kong.
Currently, Fu is the associate vice president of Hong Kong Baptist University, where he also works as the director of the Dr. Stephen Hui Research Centre of Physical Recreation and Wellness. In addition, Fu is president of the Society of Chinese Scholars on Exercise Physiology and Fitness, chairperson of Hong Kong Coach Education Committee, a research fellow of the Research Consortium of SHAPE America, and an international fellow of the National Academy of Kinesiology
mDia formins are required for cell recovery in 5-FU-induced myeloid suppression.
No full text(A) The numbers of HSPCs and committed progenitors from purified lineage-negative cells were analyzed and quantified by flow cytometer analysis by day 7 after 5-FU treatment. (B) Survival percentage of lineage-negative cells from A assayed by Annexin V staining. (C) Complete blood cell counts of wild-type or mDia1 KO mice were determined by day 7 after the first injection of 5-FU. (D) Kaplan-Meier survival analysis of indicated mice challenged with serial 5-FU injection. Error bars represent the SEM of the mean. * ppppp values. (TIFF)</p
EpCAM Aptamer Activated 5-FU-Loaded PLGA Nanoparticles in CRC Treatment; In vitro and In vivo study
No full textIn this study, EpCAM aptamer-activated nanoparticles (Ap-NPs) were synthesized to enhance treatment efficiency in colorectal cancer (CRC). PLGA [poly (D, L-lactide-co-glycolide)] copolymer was fabricated by conjugation of COOH-PEG-NH2 to PLGA-COOH through an EDC/NHS-mediated chemistry. Afterward, 5‐fluorouracil-loaded (FU) nanoparticles were prepared using the water/oil/water double emulsion solvent evaporation method. The in vitro cytotoxicity of formulations was evaluated using the MTT assay in HCT-116, CT-26, and HEK-293 cell lines. For in vivo study, tumor-bearing BALB/c mice were established by subcutaneous injection of CT-26 cell line. The results indicated that fabricated AP-FU-NPs had 101 nm size with a spherical surface, relatively homogeneously and, satisfactory encapsulation efficiency (83.93%). In vitro experiments revealed that Ap-FU-NPs had a superior in vitro cytotoxicity than both FU-NPs and free 5-FU in CT-26 and HCT-116 cells but, were significantly low toxic against HEK-293 cells relative to free 5-FU. Furthermore, in vivo results showed no significant hemolytic effect, hepatic and renal injury, or weight loss. After treatment of various animal groups with formulations, notable tumor growth delay was observed followed the order: Ap-FU-NPs The overall strategy of this study is summarized in Graphical Abstract. The present study was carried out in the three steps summarized: 1) synthesis and characterization. At first, PEG was conjugated to PLGA polymers by EDC/NHS chemistry method, then the resulting polymers were used to prepare PLGA-PEG NPs via the W/O/W technique. Finally, EpCAM Aptamers were attached to fabricated NPs. 2) In the second step cytotoxicity of formulated NPs was evaluated in vitro experiments in HEK-293, CT-26, and HCT-116 cell lines. 3) In the third step in vitro results further was investigated in CT-26 tumor-bearing BALB/c mice. “Created with BioRender.com.”</p
“Mirror Image Effect” Space Charge Distribution in XLPE Power Cable under Opposite Stressing Voltage Polarity
No full textThe paper presents space charge distributions under opposite voltage polarities in full size cross-linked polyethylene power cables using the pulsed electro-acoustic technique. Under both positive and negative polarities, space charge distributions possess similar profiles but opposite polarities. A similar phenomenon had been reported previously in plaque samples and was termed the “mirror image effect”. By comparing the results between cables treated by degassing under different conditions, the paper concludes that the “mirror image” charge distribution is mainly attributed to a bulk effect within the volume of the insulation, whilst electron transfer by tunneling through an electrode/insulator interface contributes to the generation of homo “mirror image” close to the electrodes
Effect of <i>BCL2A1</i> overexpression on 5-FU-resistance in MDA-MB-231 and T-47D.
No full textBCL2A1 protein expression of (A) MDA-MB-231 and (C) T-47D after transfection with a pCMV-Myc-DDK Entry vector (Vector) or a pCMV-Myc-DDK BCL2A1 vector (BCL2A1). Cytotoxicity of 5-FU toward (B) MDA-MB-231 transfected with a BCL2A1 vector and (D) T-47D transfected with a BCL2A1 vector. The insets show the IC50 of 5-FU against cell lines transfected with vectors. Data represent the mean with SEM of at least three independent samples (***pvs. MDA-MB-231 transfected with a control vector; *pvs. T-47D transfected with a control vector).</p
Gemcitabine: Progress in the treatment of pancreatic cancer
No full textUnresectable pancreatic cancer has a dismal prognosis with a median survival of 3-5 months in untreated disease. Since the introduction of gemcitabine, pancreatic cancer may no longer be regarded a chemotherapy-resistant tumor. Treatment with single-agent gemcitabine achieved clinical benefit and symptoms improvement in 20-30% of patients. While 1-year survival was observed in 2% of 5-fluorouracil (5-FU)-treated patients, it was raised to 18% by single-agent gemcitabine. Good treatment tolerability and low incidence of side effects are clear advantages of single-agent gemcitabine. Improvement of efficacy is, however, expected from combination treatment. Gemcitabine and cisplatin given as first-line treatment in three studies achieved a median survival of 7.4-8.3 months. One-year survival was raised to 28% as reported in one study. Comparable activity was obtained by a combination of gemcitabine with 5-FU. Nine studies using gemcitabine in combination with standard-dose or high-dose 5-FU reported a median survival ranging from 5.5 to 13 months. Notwithstanding these promising results, recommendations regarding palliative chemotherapy of pancreatic cancer remain tentative and still need confirmation by presently ongoing phase III trials. Inclusion of pancreatic cancer patients into clinical trials should be a major goal. Outside clinical trials, patients should present with an adequate PS (Karnofsky-performance index greater than or equal to 70) to qualify for chemotherapy. Copyright (C) 2001 S. Karger AG, Basel
楚辭 = Chu ci
No full textAnnotation of Chu Ci (Verses of Chu or Songs of Chu), which is an ancient anthology of Chinese poetry traditionally attributed mainly to Qu Yuan (c.340 BC-c.278 BC) and Song Yu (c.298 BC-c.222 BC) from the Warring States period (475 BC-221 BC)Fu "Qu Yuan lie zhuan" deng封面鐫"楚辭新註", "乾隆戊午年", "居易堂藏板"框20.8 x 14.9公分, 9行20字, 白口, 四周雙邊, 單黑魚尾. 版心上鐫"楚辭", 中鐫卷次及篇名附"屈原列傳"
- …
